乳腺癌新辅助化疗疗效预测因子的研究进展

被引:16
作者
陆翔
陈彩萍
韩文兰
机构
[1] 嘉兴市第一医院乳腺科
关键词
乳腺肿瘤; 新辅助化疗; 疗效预测; 综述文献;
D O I
10.16073/j.cnki.cjcpt.2012.10.005
中图分类号
R737.9 [乳腺肿瘤];
学科分类号
100214 [肿瘤学];
摘要
目的:探讨乳腺癌新辅助化疗疗效预测领域的研究进展。方法:应用PubMed及CNKI数据库系统,以"乳腺癌、新辅助化疗"为关键词,检索2008-01-2011-06的相关文献,分别获得英文文献1 056条、中文文献260条。纳入标准:1)非综述类文献;2)非动物实验和体外实验;3)研究结果中有关于疗效预测的内容。根据纳入标准,精选其中29篇有代表性的文献进行分析。结果:关于乳腺癌新辅助化疗疗效预测已开展了大量研究,其中以分子分型技术最为实用,基因芯片技术前景良好,但由于费用昂贵等缺点目前尚无法在临床推广,分子生物学指标和肿瘤形态学指标对疗效预测也有一定的作用,影像学技术则无法准确预测疗效。结论:目前尚未找到一个能完全准确预测疗效的指标,故在该领域仍有进一步研究的必要。
引用
收藏
页码:796 / 800
页数:5
相关论文
共 16 条
[1]
Blood oxygen level-dependent MRI for the monitoring of neoadjuvant chemotherapy in breast carcinoma: initial experience [J].
Fan, Bing ;
Wang, Xiao-ying ;
Yang, Xue-dong ;
Zhong, Hua ;
Wu, Chun-xue ;
Jiang, Xue-xiang .
MAGNETIC RESONANCE IMAGING, 2011, 29 (02) :153-159
[2]
The Relevance of Breast Cancer Subtypes in the Outcome of Neoadjuvant Chemotherapy [J].
Straver, M. E. ;
Rutgers, E. J. Th. ;
Rodenhuis, S. ;
Linn, S. C. ;
Loo, C. E. ;
Wesseling, J. ;
Russell, N. S. ;
Oldenburg, H. S. A. ;
Antonini, N. ;
Peeters, M. T. F. D. Vrancken .
ANNALS OF SURGICAL ONCOLOGY, 2010, 17 (09) :2411-2418
[3]
Genomic change of chromosome 8 predicts the response to taxane-based neoadjuvant chemotherapy in node-positive breast cancer [J].
Han, Sehwan ;
Park, Kyeongmee ;
Shin, Eunah ;
Kim, Hyun-Jung ;
Kim, Jung Yeon ;
Kim, Ji Young ;
Gwak, Geumhee .
ONCOLOGY REPORTS, 2010, 24 (01) :121-128
[4]
Immunohistochemical surrogate markers of breast cancer molecular classes predicts response to neoadjuvant chemotherapy.[J].RohitBhargava;SushilBeriwal;David J.Dabbs;UmutOzbek;AtillaSoran;Ronald R.Johnson;Adam M.Brufsky;Barry C.Lembersky;Gretchen M.Ahrendt.Cancer.2010, 6
[5]
Common and discriminative clinicopathological features between breast cancers with pathological complete response or progressive disease in response to neoadjuvant chemotherapy [J].
Osako, Tomo ;
Horii, Rie ;
Matsuura, Masaaki ;
Ogiya, Akiko ;
Domoto, Kaoru ;
Miyagi, Yumi ;
Takahashi, Shunji ;
Ito, Yoshinori ;
Iwase, Takuji ;
Akiyama, Futoshi .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2010, 136 (02) :233-241
[6]
Incidence of pathologic complete response in women treated with preoperative chemotherapy for locally advanced breast cancer: correlation of histology, hormone receptor status, Her2/Neu, and gross pathologic findings [J].
Alvarado-Cabrero, Isabel ;
Alderete-Vazquez, Georgia ;
Quintal-Ramirez, Marissa ;
Patino, Marcia ;
Ruiz, Erika .
ANNALS OF DIAGNOSTIC PATHOLOGY, 2009, 13 (03) :151-157
[7]
The 70-gene signature as a response predictor for neoadjuvant chemotherapy in breast cancer [J].
Straver, Marieke E. ;
Glas, Annuska M. ;
Hannemann, Juliane ;
Wesseling, Jelle ;
van de Vijver, Marc J. ;
Rutgers, Emiel J. Th. ;
Peeters, Marie-Jeanne T. F. D. Vrancken ;
van Tinteren, Harm ;
van't Veer, Laura J. ;
Rodenhuis, Sjoerd .
BREAST CANCER RESEARCH AND TREATMENT, 2010, 119 (03) :551-558
[8]
Tumour molecular subtyping according to hormone receptors and HER2 status defines different pathological complete response to neoadjuvant chemotherapy in patients with locally advanced breast cancer [J].
Sanchez-Munoz, Alfonso ;
Garcia-Tapiador, Ana Maria ;
Martinez-Ortega, Esther ;
Duenas-Garcia, Rosario ;
Jaen-Morago, Ana ;
Ortega-Granados, Ana Laura ;
Fernandea-Navarro, Monica ;
de la Torre-Cabrera, Capilla ;
Duenas, Basilio ;
Isabel Rueda, Ana ;
Morales, Francisco ;
Ramirez-Torosa, Cesar ;
Martin-Salvago, Maria Dolores ;
Sanchez-Rovira, Pedro .
CLINICAL & TRANSLATIONAL ONCOLOGY, 2008, 10 (10) :646-653
[9]
.[J]...,
[10]
Determining the morphological features of breast cancer and predicting the effects of neoadjuvant chemotherapy via diagnostic breast imaging [J].
Tsunoda-Shimizu, Hiroko ;
Hayashi, Naoki ;
Hamaoka, Tsuyoshi ;
Kawasaki, Tomonori ;
Tsugawa, Koichiro ;
Yagata, Hiroshi ;
Kikuchi, Mari ;
Suzuki, Koyu ;
Nakamura, Seigo .
BREAST CANCER, 2008, 15 (02) :133-140